These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 21778

  • 21. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T, Matsumoto S, Amejima H, Hatoyama T, Nakao M, Kagemoto A, Tanaka K, Miyazaki H.
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [Abstract] [Full Text] [Related]

  • 22. Pharmacokinetics of nisoldipine. I. Absorption, concentration in plasma, and excretion after single administration of [14C]nisoldipine in rats, dogs, monkey, and swine.
    Ahr HJ, Krause HP, Siefert HM, Suwelack D, Weber H.
    Arzneimittelforschung; 1988 Aug; 38(8):1093-8. PubMed ID: 3196402
    [Abstract] [Full Text] [Related]

  • 23. Disposition and metabolic fate of 14C-quazepam in man.
    Zampaglione N, Hilbert JM, Ning J, Chung M, Gural R, Symchowicz S.
    Drug Metab Dispos; 1985 Aug; 13(1):25-9. PubMed ID: 2858372
    [Abstract] [Full Text] [Related]

  • 24. Differences in the stereoselective pharmacokinetics of pazinaclone (DN-2327), a new anxiolytic, and its active metabolite after intravenous and oral single doses to dogs.
    Hussein Z, Mulford DJ, Bopp BA, Granneman GR.
    Drug Metab Dispos; 1993 Aug; 21(5):805-10. PubMed ID: 7902240
    [Abstract] [Full Text] [Related]

  • 25. Excretion and biotransformation of ketanserin after oral and intravenous administration in rats and dogs.
    Meuldermans W, Hendrickx J, Lauwers W, Swysen E, Hurkmans R, Knaeps F, Woestenborghs R, Heykants J.
    Drug Metab Dispos; 1984 Aug; 12(6):772-81. PubMed ID: 6150829
    [Abstract] [Full Text] [Related]

  • 26. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T, Nakajima Y, Mizobuchi M, Inazawa K, Kanazu T, Kadono K, Ohkawa T, Iwatani K.
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [Abstract] [Full Text] [Related]

  • 27. Pharmacokinetic consequences of long term coadministration of cimetidine and triazolobenzodiazepines, alprazolam and triazolam, in healthy subjects.
    Pourbaix S, Desager JP, Hulhoven R, Smith RB, Harvengt C.
    Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):447-51. PubMed ID: 2864320
    [Abstract] [Full Text] [Related]

  • 28. Disposition of the new antirheumatic agent ethyl 4-(3,4-dimethoxyphenyl)- 6,7-dimethoxy-2-(1,2,4-triazol-1-ylmethyl)quinoline-3-carboxylate (TAK-603) in rats and dogs.
    Tagawa Y, Kiyota Y, Yoshimura Y, Motohashi M, Tanayama S.
    Arzneimittelforschung; 1998 Jul; 48(7):750-7. PubMed ID: 9706376
    [Abstract] [Full Text] [Related]

  • 29. Pharmacokinetic properties of benzodiazepine hypnotics.
    Greenblatt DJ, Abernethy DR, Divoll M, Harmatz JS, Shader RI.
    J Clin Psychopharmacol; 1983 Apr; 3(2):129-32. PubMed ID: 6132931
    [Abstract] [Full Text] [Related]

  • 30. Absorption, disposition, and metabolism of trans-methyl styryl ketone in female B6C3F1 mice.
    Sauer JM, Bao J, Smith RL, Kuester RK, Mayersohn M, Sipes IG.
    Drug Metab Dispos; 1997 Oct; 25(10):1184-90. PubMed ID: 9321522
    [Abstract] [Full Text] [Related]

  • 31. Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 3rd communication: plasma concentrations of the unchanged drug and its deethylated metabolite in rats, dogs and monkeys.
    Nakamura A, Hirota T, Sugihara K, Morino A.
    Arzneimittelforschung; 1997 Feb; 47(2):169-74. PubMed ID: 9079236
    [Abstract] [Full Text] [Related]

  • 32. Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat.
    Sauer JM, Smith RL, Bao J, Kattnig MJ, Kuester RK, McClure TD, Mayersohn M, Sipes IG.
    Drug Metab Dispos; 1997 Jun; 25(6):732-9. PubMed ID: 9193875
    [Abstract] [Full Text] [Related]

  • 33. The pharmacokinetics of nitrendipine. I. Absorption, plasma concentrations, and excretion after single administration of [14C]nitrendipine to rats and dogs.
    Krause HP, Ahr HJ, Beermann D, Siefert HM, Suwelack D, Weber H.
    Arzneimittelforschung; 1988 Nov; 38(11):1593-9. PubMed ID: 3214442
    [Abstract] [Full Text] [Related]

  • 34. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites.
    Prakash C, Cui D.
    Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030
    [Abstract] [Full Text] [Related]

  • 35. Physiological disposition and metabolism of timolol in man and laboratory animals.
    Tocco DJ, Duncan AE, Delauna FA, Hucker HB, Gruber VF, Vandenheuvel WJ.
    Drug Metab Dispos; 1975 Dec; 3(5):361-70. PubMed ID: 241617
    [Abstract] [Full Text] [Related]

  • 36. Disposition of [14C]velnacrine maleate in rats, dogs, and humans.
    Turcan RG, Hillbeck D, Hartley TE, Gilbert PJ, Coe RA, Troke JA, Vose CW.
    Drug Metab Dispos; 1993 Dec; 21(6):1037-47. PubMed ID: 7905382
    [Abstract] [Full Text] [Related]

  • 37. Metabolism and excretion of the novel antipsychotic drug ziprasidone in rats after oral administration of a mixture of 14C- and 3H-labeled ziprasidone.
    Prakash C, Kamel A, Anderson W, Howard H.
    Drug Metab Dispos; 1997 Feb; 25(2):206-18. PubMed ID: 9029052
    [Abstract] [Full Text] [Related]

  • 38. Metabolism, distribution and excretion of a selective N-methyl-D-aspartate receptor antagonist, traxoprodil, in rats and dogs.
    Prakash C, Cui D, Potchoiba MJ, Butler T.
    Drug Metab Dispos; 2007 Aug; 35(8):1350-64. PubMed ID: 17496205
    [Abstract] [Full Text] [Related]

  • 39. Metabolism of MK-499, a class III antiarrhythmic agent, in rats and dogs.
    Vickers S, Duncan CA, Slaughter DE, Arison BH, Greber T, Olah TV, Vyas KP.
    Drug Metab Dispos; 1998 May; 26(5):388-95. PubMed ID: 9571219
    [Abstract] [Full Text] [Related]

  • 40. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse.
    Sauer JM, Bao J, Smith RL, McClure TD, Mayersohn M, Pillai U, Cunningham ML, Sipes IG.
    Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.